Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker CLOV
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 20, 2026 | Karen Soares Chief Legal Officer | CLOV Clover Health Investments, Corp. | Sale | 19,275 | $4.66 | $89.8K Sale | Form 4 ↗ |
| Oct 19, 2026 | Jamie L. Reynoso CEO, Medicare Advantage | CLOV Clover Health Investments, Corp. | Sale | 4,066 | $4.41 | $17.9K Sale | Form 4 ↗ |
| Oct 15, 2026 | Andrew Toy Chief Executive Officer, Director | CLOV Clover Health Investments, Corp. | Sale | 62,176 | $4.68 | $291.0K Sale | Form 4 ↗ |
| Oct 15, 2026 | Karen Soares Chief Legal Officer | CLOV Clover Health Investments, Corp. | Sale | 14,673 | $4.68 | $68.7K Sale | Form 4 ↗ |
| Oct 15, 2026 | Joseph Clay Thornton Interim CFO | CLOV Clover Health Investments, Corp. | Sale | 4,591 | $4.68 | $21.5K Sale | Form 4 ↗ |
| Oct 15, 2026 | Conrad Wai CEO, Counterpart Health | CLOV Clover Health Investments, Corp. | Sale | 23,627 | $4.68 | $110.6K Sale | Form 4 ↗ |
| Oct 15, 2026 | Jamie L. Reynoso CEO, Medicare Advantage | CLOV Clover Health Investments, Corp. | Sale | 18,273 | $4.68 | $85.5K Sale | Form 4 ↗ |
| Sep 17, 2026 | Jamie L. Reynoso CEO, Medicare Advantage | CLOV Clover Health Investments, Corp. | Sale | 1,921 | $4.56 | $8,760 Sale | Form 4 ↗ |
| Sep 16, 2026 | Joseph Frank Oldakowski VP OF FINANCE AND CONTROLLER | CLOV Clover Health Investments, Corp. | Sale | 3,170 | $4.64 | $14.7K Sale | Form 4 ↗ |
| Sep 15, 2026 | Karen Soares Chief Legal Officer | CLOV Clover Health Investments, Corp. | Sale | 6,846 | $4.78 | $32.7K Sale | Form 4 ↗ |
| Sep 15, 2026 | Conrad Wai CEO, Counterpart Health | CLOV Clover Health Investments, Corp. | Sale | 300,000 | $4.72 | $1.4M Sale | Form 4 ↗ |
| Sep 15, 2026 | Jamie L. Reynoso CEO, Medicare Advantage | CLOV Clover Health Investments, Corp. | Sale | 9,273 | $4.78 | $44.3K Sale | Form 4 ↗ |
| Sep 14, 2026 | Joseph Frank Oldakowski VP OF FINANCE AND CONTROLLER | CLOV Clover Health Investments, Corp. | Sale | 20,000 | $5.16 | $103.2K Sale | Form 4 ↗ |
| Aug 17, 2026 | Joseph Clay Thornton Interim CFO | CLOV Clover Health Investments, Corp. | Sale | 17,775 | $4.39 | $78.0K Sale | Form 4 ↗ |
| Aug 10, 2026 | Andrew Toy Chief Executive Officer, Director | CLOV Clover Health Investments, Corp. | Sale | 87,798 | $4.65 | $408.3K Sale | Form 4 ↗ |
| Jul 20, 2026 | Karen Soares Chief Legal Officer | CLOV Clover Health Investments, Corp. | Sale | 51,700 | $4.51 | $233.2K Sale | Form 4 ↗ |
| Jul 17, 2026 | Jamie L. Reynoso CEO, Medicare Advantage | CLOV Clover Health Investments, Corp. | Sale | 4,839 | $4.53 | $21.9K Sale | Form 4 ↗ |
| Jul 15, 2026 | Andrew Toy Chief Executive Officer, Director | CLOV Clover Health Investments, Corp. | Sale | 62,711 | $4.67 | $292.9K Sale | Form 4 ↗ |
| Jul 15, 2026 | Conrad Wai CEO, Counterpart Health | CLOV Clover Health Investments, Corp. | Sale | 24,215 | $4.67 | $113.1K Sale | Form 4 ↗ |
| Jul 15, 2026 | Jamie L. Reynoso CEO, Medicare Advantage | CLOV Clover Health Investments, Corp. | Sale | 13,119 | $4.67 | $61.3K Sale | Form 4 ↗ |
| Jul 15, 2026 | Karen Soares Chief Legal Officer | CLOV Clover Health Investments, Corp. | Sale | 10,519 | $4.67 | $49.1K Sale | Form 4 ↗ |
| Jul 15, 2026 | Joseph Clay Thornton Interim CFO | CLOV Clover Health Investments, Corp. | Sale | 4,630 | $4.67 | $21.6K Sale | Form 4 ↗ |
| Jul 8, 2026 | Jamie L. Reynoso CEO, Medicare Advantage | CLOV Clover Health Investments, Corp. | Sale | 2,384 | $4.68 | $11.2K Sale | Form 4 ↗ |
| Jul 6, 2026 | Jamie L. Reynoso CEO, Medicare Advantage | CLOV Clover Health Investments, Corp. | Sale | 6,229 | $5.26 | $32.8K Sale | Form 4 ↗ |
| Jul 1, 2026 | Andrew Toy Chief Executive Officer, Director | CLOV Clover Health Investments, Corp. | Sale | 313,476 | $5.32 | $1.7M Sale | Form 4 ↗ |
| Jun 17, 2026 | Jamie L. Reynoso CEO, Medicare Advantage | CLOV Clover Health Investments, Corp. | Sale | 2,360 | $4.78 | $11.3K Sale | Form 4 ↗ |
| Jun 16, 2026 | Joseph Frank Oldakowski VP OF FINANCE AND CONTROLLER | CLOV Clover Health Investments, Corp. | Sale | 12,102 | $4.86 | $58.8K Sale | Form 4 ↗ |
| Jun 15, 2026 | Jamie L. Reynoso CEO, Medicare Advantage | CLOV Clover Health Investments, Corp. | Sale | 6,350 | $4.61 | $29.3K Sale | Form 4 ↗ |
| Jun 15, 2026 | Karen Soares Chief Legal Officer | CLOV Clover Health Investments, Corp. | Sale | 4,681 | $4.61 | $21.6K Sale | Form 4 ↗ |
| Jun 11, 2026 | Jamie L. Reynoso CEO, Medicare Advantage | CLOV Clover Health Investments, Corp. | Sale | 7,289 | $4.91 | $35.8K Sale | Form 4 ↗ |
| May 28, 2026 | Conrad Wai CEO, Counterpart Health | CLOV Clover Health Investments, Corp. | Sale | 220,426 | $3.99 | $879.5K Sale | Form 4 ↗ |
| May 18, 2026 | Carladenise Armbrister Edwards Director | CLOV Clover Health Investments, Corp. | Sale | 67,160 | $3.42 | $229.7K Sale | Form 4 ↗ |
| May 13, 2026 | Brady Patrick Priest CEO of Clover Care Services | CLOV Clover Health Investments, Corp. | Sale | 98,039 | $3.52 | $345.1K Sale | Form 4 ↗ |
| Mar 18, 2026 | Jamie L. Reynoso CEO, Medicare Advantage | CLOV Clover Health Investments, Corp. | Sale | 5,833 | $1.91 | $11.1K Sale | Form 4 ↗ |
| Mar 4, 2026 | Brady Patrick Priest CEO of Home Care | CLOV Clover Health Investments, Corp. | Sale | 175,000 | $2.17 | $379.8K Sale | Form 4 ↗ |
| Jan 20, 2026 | Jamie L. Reynoso CEO, Medicare Advantage | CLOV Clover Health Investments, Corp. | Sale | 4,597 | $2.58 | $11.9K Sale | Form 4 ↗ |
| Jan 7, 2026 | Jamie L. Reynoso CEO, Medicare Advantage | CLOV Clover Health Investments, Corp. | Sale | 2,102 | $2.53 | $5,318 Sale | Form 4 ↗ |
| Dec 18, 2025 | Jamie L. Reynoso CEO, Medicare Advantage | CLOV Clover Health Investments, Corp. | Sale | 4,913 | $2.61 | $12.8K Sale | Form 4 ↗ |
| Nov 4, 2025 | Jamie L. Reynoso CEO, Medicare Advantage | CLOV Clover Health Investments, Corp. | Sale | 30,385 | $3.58 | $108.8K Sale | Form 4 ↗ |
| Oct 17, 2025 | Jamie L. Reynoso CEO, Medicare Advantage | CLOV Clover Health Investments, Corp. | Sale | 16,514 | $2.69 | $44.4K Sale | Form 4 ↗ |
| Oct 7, 2025 | Jamie L. Reynoso CEO, Medicare Advantage | CLOV Clover Health Investments, Corp. | Sale | 2,012 | $2.65 | $5,332 Sale | Form 4 ↗ |
| Sep 17, 2025 | Jamie L. Reynoso CEO, Medicare Advantage | CLOV Clover Health Investments, Corp. | Sale | 4,914 | $3.09 | $15.2K Sale | Form 4 ↗ |
| Aug 13, 2025 | Anna U. Loengard Director | CLOV Clover Health Investments, Corp. | Buy | 14,500 | $2.59 | $37.6K Buy | Form 4 ↗ |
| Aug 13, 2025 | Anna U. Loengard Director | CLOV Clover Health Investments, Corp. | Buy | 12,000 | $2.60 | $31.2K Buy | Form 4 ↗ |
| Aug 8, 2025 | Vivek Garipalli Director, 10% owner | CLOV Clover Health Investments, Corp. | Buy | 31,980 | $2.17 | $69.4K Buy | Form 4 ↗ |
| Aug 7, 2025 | Vivek Garipalli Director, 10% owner | CLOV Clover Health Investments, Corp. | Buy | 415,000 | $2.24 | $929.6K Buy | Form 4 ↗ |
| Aug 4, 2025 | Jamie L. Reynoso CEO, Medicare Advantage | CLOV Clover Health Investments, Corp. | Sale | 6,823 | $2.89 | $19.7K Sale | Form 4 ↗ |
| Jul 23, 2025 | Conrad Wai CEO, Counterpart Health | CLOV Clover Health Investments, Corp. | Sale | 91,197 | $3.32 | $302.8K Sale | Form 4 ↗ |
| Jul 22, 2025 | Conrad Wai CEO, Counterpart Health | CLOV Clover Health Investments, Corp. | Sale | 118,600 | $3.29 | $390.2K Sale | Form 4 ↗ |
| Jul 8, 2025 | Conrad Wai CEO, Counterpart Health | CLOV Clover Health Investments, Corp. | Sale | 15,203 | $3.26 | $49.6K Sale | Form 4/A ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 11:34 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances